ClinicalTrials.gg
RecruitingNCT07042087LIBRA REMINDUpdated Jun 27, 2025

Lifestyle for the BRAin Health - Time Restricted Eating and Mindfulness

An interventional study of Mindfulness Yoga and Time-Restricted Eating with nutritional counseling promoting a flexitarian dietary pattern in Alzheimer Disease, Aging and Lifestyle Factors, sponsored by St. Anne's University Hospital Brno, Czech Republic. Recruiting at 1 site in Czechia. Open to participants aged 60 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-06-27.

Sponsored by St. Anne's University Hospital Brno, Czech Republic · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Nov 2024, registered Jun 2025).
  • Started Nov 2024; still recruiting 2 years later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
60 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 70 studies in Alzheimer Disease with a site in Czechia — 14 open to participants now, 18 under way, 8 of them phase 3. Alzheimer Disease · Czechia.

Planned enrollment
65th of 68
48 · median 434
Started
2024
with 3 others
No phase
6 of 70
5 open now
Primary completion
2026-12
later than 7 of 17 live
Registered
65th of 70
by date

Among the 70 studies in Alzheimer Disease with a site in Czechia, this one is the 65th largest by planned enrollment of the 68 interventional ones that give a count, is one of 4 that started in 2024, is one of 6 with no phase, reaches primary completion later than 7 of the 17 other live ones, and was the 65th registered.

Alzheimer Disease

3,972 studies on the registry are indexed under Alzheimer Disease; 930 are open to participants now.

Browse Alzheimer Disease studies →

Open to participants now

14 of the 70 studies in Alzheimer Disease with a site in Czechia are open now. Recruiting first, the newest first:

8 more — sign in →

All 14 open studies →

A study can be open while its sites in Czechia have not opened yet or have stopped. Only those recruiting at a site in Czechia →

Who these studies take

Of the 645 Alzheimer Disease studies recruiting now, 282 (44%) set no upper age limit and 57 (9%) stop at 75 or younger; 34 take children under 18; 288 take healthy volunteers.

This study: 60 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 70 studies in Alzheimer Disease with a site in Czechia, or all of them as a file.
02

Study summary

The study aims to evaluate the effects of a 9-month intervention combining yoga-based mindfulness techniques, cognitive training, and nutritional counseling on cognitive function, plasma markers of neurodegeneration (tau protein), physical fitness, and metabolism in older adults at increased risk of developing Alzheimer's disease.

Read the detailed description

This randomized two-arm clinical trial aims to evaluate the effects of a 9-month intervention combining yoga-based mindfulness techniques and time-restricted eating (Arm 1) versus cognitive training and stretching (Arm 2) in older adults at increased risk of developing Alzheimer's disease. The study will assess outcomes including cognitive function, plasma biomarkers of neurodegeneration (tau protein), physical fitness, and metabolic health.

The trial is harmonized with the concurrently running LIBRA-NET study (NCT06986096) conducted at Slovak sites (Bratislava and Banská Bystrica). Data from the cognitive training arm and additional clinical parameters will be pooled across both studies for joint statistical analyses. The studies share primary and several secondary outcomes, a shared intervention timeline, assessment protocols, and the cognitive training/stretching arm. The harmonization across all four study sites aims to increase statistical power and enable more generalizable conclusions for a larger population.

03

Conditions studied

  • Alzheimer Disease
  • Aging
  • Lifestyle Factors
  • Cognitive Impairment
  • Yoga
  • Time Restricted Eating
  • Diet Modification

Keywords

  • Alzheimer's Disease Prevention
  • Mindfulness-Based Intervention
  • Cognitive Training
  • Time-Restricted Eating
  • Dietary consultation
04

Who can participate

Ages eligible
60 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 60-80 years
  • Diagnosis of Subjective Cognitive Impairment (SCI) or Mild Cognitive Impairment (MCI)
  • mini-mental-scale () score between 24-30
  • Positive plasma pTau217 biomarker
  • Stable dose of iAChE therapy (if applicable)
  • Ability to participate in a 9-month intervention

Exclusion criteria

Exclusion Criteria:

  • Stroke or myocardial infarction within the past year
  • Decompensated internal conditions (e.g., severe heart failure, kidney failure, unstable diabetes, GLP1 agonist therapy)
  • Long-term psychiatric treatment (except well-managed depression)
  • Neurological conditions affecting mobility or cognition (e.g., Parkinson's disease, severe tremor, epilepsy)
  • Severe sensory or motor impairment preventing protocol participation
  • Active cancer treated within the past 5 years
  • Poor anticipated compliance (e.g., transport issues, time constraints, non-cooperation)
  • Concurrent participation in another clinical study
  • Unstable iAChE medication regimen
  • Substance or alcohol dependence
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
48 participants (estimated)

Study arms

  • Experimental
    Mindfulness Yoga and Time-Restricted Eating Intervention

    Participants in this arm will take part in a 9-month intervention consisting of yoga-based mindfulness sessions combined with time-restricted eating (16:8 protocol). The yoga program includes physical postures (asanas), breathing techniques, and meditation, aimed at improving physical fitness, stress regulation, and cognitive function. The dietary component promotes a flexitarian diet within an 8-hour daily eating window. Sessions are conducted twice weekly for 90 minutes under certified instructors.

    Behavioral: Mindfulness Yoga · Behavioral: Time-Restricted Eating with nutritional counseling promoting a flexitarian dietary pattern

  • Active comparator
    Cognitive Training and Stretching Intervention

    Participants in this arm will engage in a 9-month intervention including cognitive training exercises and guided stretching. The cognitive program targets multiple domains: verbal and non-verbal memory, executive functions, attention, language, and social cognition. Sessions are delivered twice weekly for 90 minutes by trained therapists. This intervention serves as an active comparator for assessing the effects of yoga and dietary modification on cognitive and biological outcomes.

    Behavioral: Cognitive Training · Behavioral: Stretching

Interventions

  • BehavioralMindfulness Yoga

    A structured 9-month program integrating physical yoga postures (asanas), breathing techniques, sound, and meditation. Sessions are conducted twice weekly (90 minutes each) and focus on enhancing physical health, stress regulation, and cognitive performance. Delivered by certified instructors.

  • BehavioralTime-Restricted Eating with nutritional counseling promoting a flexitarian dietary pattern

    Participants follow a 16:8 time-restricted eating schedule (16 hours fasting / 8 hours eating window) for 9 months, with nutritional counseling promoting a flexitarian dietary pattern. The intervention is designed to support metabolic health and reduce risk factors for neurodegeneration.

  • BehavioralCognitive Training

    A 9-month structured program of twice-weekly cognitive training sessions (90 minutes each), targeting memory, attention, executive function, and social cognition using both paper-based and computer-based tasks. Supervised by trained therapists.

  • BehavioralStretching

    A twice-weekly stretching routine performed over 9 months (90-minute sessions), led by physiotherapists. This intervention provides low-intensity physical activity to control for physical engagement across study arms.

06

What researchers measure

Primary outcomes

  1. Composite Score of Cognitive Function

    Change in composite neuropsychological score from baseline to post-intervention (9 months), including domain-specific scores for memory, executive function/attention, and psychomotor speed.

    Time frame: Baseline and 9 months

  2. Plasma Biomarkers of Neurodegeneration

    Change in concentrations of plasma biomarkers: phosphorylated tau (pTau217, pTau181), GFAP, and neurofilament light chain (NfL).

    Time frame: Baseline and 9 months

Secondary outcomes

  1. Computerized Cognitive Test Scores - Cogstate

    Change in individual and composite scores on computerized cognitive tests (e.g., Cogstate), including measures of spatial orientation.

    Time frame: Baseline and 9 months

  2. Geriatric depression scale

    Changes in depression, using the GDS scale

    Time frame: Baseline and 9 months

  3. Adherence to Intervention

    Attendance rate and adherence to prescribed intervention protocol (minimum attendance threshold and dietary compliance).

    Time frame: Throughout the 9-month intervention

  4. Beck's anxiety inventory

    Anxiety levels measured by the BAI

    Time frame: Baseline and 9 months

  5. Older People's Quality of Life Questionnaire scores

    Quality of life measured by OPQOL-35

    Time frame: Time Frame: Baseline and 9 months

07

Study locations

1 of 1 sites recruiting
  • Fnusa/ Icrc
    Brno, 64400, Czechia
    Recruiting
    • Kurečková Kurečková, Ing. · Contactmonika.kureckova@fnusa.cz · +420 54 318 4086
    • Kateřina Sheardova, MD. PhD. · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2024 (actual). Primary completion is estimated for Dec 2026, 25 months after the start.

Of 887 non-industry interventional studies with no phase under Alzheimer Disease, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 51. This study's planned 25 months is below that.

Counting every sponsor, half of 964 studies reached it within 29 months; a quarter within 15 and three quarters within 51.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 11, 2025
First posted
Jun 27, 2025
StartActual
Nov 1, 2024
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Jun 27, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 27, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07042087
Lead sponsor
St. Anne's University Hospital Brno, Czech Republic
Collaborators
Slovak Academy of Sciences
Responsible party
Sponsor
First posted
Jun 27, 2025
Start date
Nov 1, 2024
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Jun 27, 2025

Study contacts

Kateřina Sheardova, MD. PhD.
principal investigator · The International Clinical Research Center of St. Anne's University Hospital in Brno (FNUSA-ICRC)

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion